Study of DCC-3014 in Patients With Advanced Tumours and Tenosynovial Giant Cell Tumour

Trial Status: Recruiting
Start Date: February, 2017
Expected Enrolment: 120
Type of Trial: N/A
Protocol IDs: NCT03069469, DCC-3014-01-001
Trial Design: Allocation: N/A
Intervention Model: Sequential Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Trial Phase: Phase 1/Phase 2
Medical Conditions: Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Tenosynovial Giant Cell Tumor, Diffuse
Drugs: DCC-3014
Lead Sponsor: Deciphera Pharmaceuticals LLC
Sponsors/Study Groups: None specified
Type of Treatment: None specified
Principal Investigator(s): Maitreyi Sharma, MD, Deciphera Pharmaceuticals LLC
Date posted on February 20, 2017
Last updated: December 23, 2021
This trial was imported from

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society